Open original FDA record ↗Recall record
- FDA identifier
- Z-0558-2022
- Company in FDA record
- CELLTRION USA INC
- FDA record creation date
- Feb 3, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The European version of the DiaTrust COVID-19 Ag Rapid Test is not approved for marketing in the U.S. but was illegally distributed in the U.S. The packaging and labeling of the European test kit is different from the US test kit and is NOT authorized for distribution in the US.
Source facts
- Action
- Celltrion Healthcare informs Celltrion USA on 2021-11-11 that it had sent cease and desist letter to distributors who were illegally distributing non-EUA product in the U.S. Celltrion demanded return of all EU product from distributors' inventory and demanded removal of all EU DiaTrustTests from the U.S. In addition, the firm sent letters to all EU distributors warning against diversion and obtaining confirmation that distributors understand limitations on distribution only within the EU.
- Initiated
- 2021-12-01
- Root cause
- No Marketing Application
- Terminated
- 2024-06-17
- Distribution
- US Nationwide distribution in the state of CA.
- Recall number
- Z-0558-2022
- Recall status
- Terminated
- CDRH record ID
- 191625
- FDA record created
- 2022-02-03
- Recall event number
- 89455